Search
NEWS
CHIP søger jurastuderende
CHIP søger jurastuderende
Ansøgningsfrist 22-06-2018
Se stillingsannonce her
NEW PERSIMUNE publication
Rapid estimation of severity of new pandemic influenza types is essential to gauge appropriate level of intervention; the some severe the more intense the intervention. During the 2009 pandemic, Mexican authorities reported substantial severity expressed as a high case fatality rate. In this report, prof Lone Simonsen from CHIP/PERSIMUNE at Righospitalet uses data from a global cohort study lead by INSIGHT to estimate this rate, and find that it was 16 fold lower than initial estimates. These observations can be used to more reliable assess severity in next influenza pandemic. Find the full publication here
Next Immunologic Colloquim 18 April 2018

The next Immunologic Colloquium will take place 18 April 2018 15.30-16.30 at Rigshospitalet Department of Infectious Diseases.

Agenda

2 day course on Introduction to Cost-effectiveness Analysis for Infectious Diseases
25th - 26th September 2018 at UCL Royal Free Campus, London

The course is for people working in health care settings, academic environments, industry and governmental and non-governmental organisations who wish to achieve a basic understanding of, and be able to interpret, cost effectiveness analyses in the context of infectious diseases, with particular focus on HIV

Read more about the course and sign up here
CHIP and INSIGHT mourn the loss of Professors David Cooper and Fred Gordin who passed away 18 March
It is with incredible sadness that we have learned of the passing of two pillars of the INSIGHT network, Fred Gordin in Washington DC and David Cooper in Sydney. 

Fred’s leadership in INSIGHT was unparalleled. He directed the Washington International Coordinating Centre, chaired CPCRA, the SMART and currently the START protocol. Fred’s scientific interests focused on pulmonary disease, and his life-long leadership in tuberculosis research is widely acknowledged. 
David led the Sydney International Coordinating Centre of INSIGHT. David was a central figure in global HIV research for more than three decades and in forming INSIGHT’s studies and research output over the years. The Kirby Institute @ UNSW embodies David’s leadership. As former president of IAS and builder of research structures in Bangkok and elsewhere in Asia, David was an inspiring and visionary leader. 

Fred and David will be sorely missed. Our thoughts are with their friends and families. 

CHIP and INSIGHT honor their legacy.
New WHO surveillance protocol for viral hepatitis
The World Health Organization calls for better monitoring of viral hepatitis with the launch of a new protocol. The objective of the protocol is to improve the understanding of the link between viral hepatitis and the 2 main consequences: cirrhosis and hepatocellular carcinoma. Better understanding of linkages between viral hepatitis and liver cancer will be key to improving global and national policies and strategies to reduce deaths caused by both diseases.
The late presentation definition used in the protocol builds on a consensus definition developed in 2017 involving authors from CHIP

Read the full publication here:
Late presentation of chronic viral hepatitis for medical care: a consensus definition. Mauss et al.

Find the new WHO protocol for surveillance of viral hepatitis here
HIV training and mentoring programme

CHIP has launched the HIV training and mentoring programme for Ukrainian doctors in collaboration with WHO Regional Office in Ukraine. During this week the Ukrainian doctors will visit different hospitals in Copenhagen Region and other health institutions to meet the infectious diseases specialists who will share their knowledge and present on international standards for HIV treatment and care. 

CROI 2018
Conference on Retroviruses and Oppertunistic Infections 4 -7 March 2018.
CHIP will be represented at CROI 2018 with 2 presentations.
Please find all presentations here
Can hypothermia reduce organ dysfunction and mortality in patients with septic shock?
Read more about the results of the latest PERSIMUNE research which was published in Lancet Respiratory Medicine.
New publication: Results from the Copenhagen Comorbidity in HIV Infection (COCOMO) Study
Marco Gelpi and collegues from the Copenhagen Comorbidity in HIV Infection (COCOMO) Study affiliated with PERSIMUNE recently reported data indicating that even well-treated and in particular older HIV-positive persons remains having a distrinct pro-atherogenic phenotype compared to age and gender matched sections of the general population. This observation renders supports for notions from other sections of research by CHIP and PERSIMUNE, that HIV status is an independent risk factor for cardiovascular disease.  Research focused on identifying mechanisms explaining the development of the phenotype and interventions to contract its likely adverse reactions is underway. 
Abstract
Wall of fame PERSIMUNE Data Warehouse
Acknowledgement of the huge work done in relation to the establishment of the PERSIMUNE Datawarehouse
See the Wall of Fame for the PERSIMUNE Data Warehouse





 
MISP - Talks: The new horizon in biomedicine
Join the MISP - Talks: The new horizon in biomedicine 
8 December 2017 16-19 
Jerne Auditorium in Mærsk Tower
The Panum Institute

Open to all, scientists and general public.
The MISP talks are a series of forward looking talks on precision
medicine and the emerging new science frontiers and technologies,
presented by leading international experts.

Please find full programme and register for the event here
EACS Guidelines 9.0
In relation to the recent EACS conference in Milan, Version 9.0 of the EACS Guidelines was launched. The massive work in reviewing and updating the EACS Guidelines is led by Prof Manuel Battegay with the support of Dr. Lene Ryom from CHIP.
The guidelines are an essential tool for clinicians assisting their work in the fast evolving field of HIV treatment. Version 9.0 of the Guidelines includes revisions to the sections on antiretroviral treatment, co-morbidities, opportunistic infections and Hepatitis C.

Read more about the latest updates and the work around the EACS Guidelines here
Find the latest version of the EACS Guidelines here

 
EACS 2017
16th European AIDS Conference 25-27 October 2017, Milan, Italy

CHIP is represented with 7 presentations at EACS 2017, 2 oral presentations and 5 poster presentations

Please find all presentations HERE
Available positions at CHIP
CHIP is looking to fill a position as Post Doc in biostatistics and is also hiring a student for our IT department. Read more about the positions HERE
ID WEEK 2017 - San Diego 4-8 October 2017
CHIP will be represented at IDWEEK 2017 with 8 presentations. 
1 oral presentation and 7 poster presentations.

See all presentations here
Launch of the Joint Action - INTEGRATE
19t September the Joint Action on integrating prevention, testing and link to care strategies across HIV, viral hepatitis, TB and STIs in Europe - INTEGRATE - will be launched.

INTEGRATE is funded by the 3rd EU Health Programme and will run over three years (September 2017-August 2020)

The main objective of INTEGRATE is to integrate early diagnosis and linkage to prevention and care of HIV, viral hepatitis, TB and STIs in EU member states by 2020.

Press Release from the European Commission

Read mroe about the Joint Action INTEGRATE here

For more information follow INTEGRATE on Facebook and Twitter

 
New EU project

CHIP will be the coordinator for the new EU funded Joint Action INTEGRATE. The launch of INTEGRATE will happen in Brussels 19 September 2017 where the EU commissioner for Food and Health will participate.
Read more here
  • ​
  • ​
Privacy Policy   |  Sitemap
Login